In MTC, it has been suggested that tumour-associated CTLA-4 expression is exclusive to sporadic cases [58] and may contribute to the stage-adjusted worse prognosis seen when comparing sporadic and hereditary disease [59]. This evidence concerns the gene CTLA4 and neoplasm.